Today we're announcing that Varda has raised a $90 million Series B funding round, led by Caffeinated Capital, with participation from Lux Capital, General Catalyst, Founders Fund, and Khosla Ventures. Our core mission, and biggest challenge, is to expand the economic bounds of human kind by creating a microgravity-enabled life sciences sector. In February, the W-1 spacecraft became the first ever fully autonomous, free-flying commercial spacecraft to land on US soil, bringing with it new insights, inspiration, and the chance to make an impact on the future of human health. “In the world of deeply ambitious startups, you almost never see anyone say, ‘Here’s my plan, I’m going to go get it done,’ and it actually happens. Varda is one of the few that gets it done, which is why we are thrilled to continue supporting them,” said Raymond Tonsing, Founder and Managing Partner at Caffeinated Capital.
Congratulations on all of your recent accomplishments & excellent progress. 🦾🌌🚀
Excited to hear if there are any new medical applications for the form-3 ritonavir from this mission! Microgravity pharmaceutical development could be a huge market going forward and I'm looking forward to hearing more from Varda.
Congrats y'all! Well deserved!! Looking forward to the next few years 🥳🤘
Congrats everyone, that is a major accomplishment!
Congrats!
Congratulations Varda Space Industries!!! To infinite and beyond... and then back to Earth 🚀 💊
Love your marketing!!
Way to Go!!!!
Biomanufacturing | Space Life Sciences Consulting
3moCongrats! Varda has cleared some significant hurdles, but now comes the hardest one: establishing a consistent customer base for this service. Please make me a believer again in this field! 😁